NOVEL CELL SORTING AND SEPARATION MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: MD-R-2024-11-27-147592 |   Health Care

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Novel Cell Sorting and Separation Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL NOVEL CELL SORTING AND SEPARATION MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL NOVEL CELL SORTING AND SEPARATION MARKET

7.1 GLOBAL NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA NOVEL CELL SORTING AND SEPARATION MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 NanoCellect Biomedical (United States)

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Innovative Biochips (United States)

16.3 Fluidigm Corporation (United States)

16.4 LumaCyte (United States)

16.5 Union Biometrica (United States)

16.6 LevitasBio (United States)

16.7 RareCyte (United States)

16.8 Cytonome (United States)

16.9 Akadeum Life Sciences (United States)

16.10 QIAGEN (Germany)

16.11 Namocell(United States)

16.12 STEMCELL Technologies (Canada)

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

By Type
Cancer Cell
Immune Cells
Microbial Cell
Red Blood Cell/Platelet
Stem Cell
Others
By Application
Academic Institutes
Clinical Testing Labs
Hospitals
Commercial Organizations
Others
By Cell sorting technology
Buoyancy-activated
Magnetophoretics
Microfluidics
Optoelectronics
Other advanced technologies

By Cell Separation Methods
Physicochemical
Affinity-based methods
Biophysical-based methods
Others

By Size of cell
< 5 m
5-10 m
10-15 m
15-25 m
> 25 m

By Type of Offering
Cell sorters
Consumables and isolation kits

By End User
Cell Research
Biomedical Diagnosis
Other

Companies

NanoCellect Biomedical (United States)
Innovative Biochips (United States)
Fluidigm Corporation (United States)
LumaCyte (United States)
Union Biometrica (United States)
LevitasBio (United States)
RareCyte (United States)
Cytonome (United States)
Akadeum Life Sciences (United States)
QIAGEN (Germany)
Namocell(United States)
STEMCELL Technologies (Canada)

Single User License  : 3900$
Corporate License    : 7800$
Enquiry Before Buying
Request For Customization
Speak To Analyst

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE

    • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY

    • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH

    • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING

    • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.